Acute intermittent porphyria
|
Orthotopic liver transplantation
|
Bronchiolitis obliterans syndrome
|
Extracorporeal photopheresis
|
Central serous chorioretinopathy
|
Photodynamic therapy
|
Crigler-Najjar syndrome, type 1
|
Orthotopic liver transplantation
|
| Cystic fibrosis |
Intrapulmonary percussive ventilation
|
Cystic fibrosis-related diabetes with fasting hyperglycemia
|
External infusion pumps for insulin
|
Hashimoto’s encephalopathy
|
Off-label use of intravenous immune globulin
|
Hodgkin’s disease
|
Off-label use of rituximab
|
Immunoglobulin A nephropathy (proliferative glomerulonephritis)
|
Off-label use of rituximab
|
Laryngeal cleft, type 1
|
Radiesse® Voice laryngoplasty injections
|
Liver metastases from gastric cancer
|
Radiofrequency Ablation
|
Neuromyelitis optica
|
Off-label use of rituximab
|
Primary plasma cell leukemia
|
Allogeneic hematopoietic cell transplant
|
Pseudomyxoma peritonei
|
Hyperthermic intraperitoneal chemotherapy (in conjunction with cytoreductive surgery or peritonectomy)
|
Pseudotumor cerebri
|
Intracranial angioplasty with stenting |
Recurrent glioblastoma
|
NovoTTF-100A system
|
Retinal astrocytic hamartoma in tuberous sclerosis
|
Photodynamic therapy with Visudyne
|
Sacral chordoma
|
Post-operative proton beam radiosurgery/radiotherapy
|
Unresectable liver metastases from neuroendocrine tumors
|
Off-label use of selective internal radiation therapy with yttrium-90 microspheres
|